SIGNALAI·Jun 26, 2026, 4:00 AMSignal75Medium term

A Guideline-Aware AI Agent for Zero-Shot Target Volume Auto-Delineation

Source: arXiv cs.AI

Share
A Guideline-Aware AI Agent for Zero-Shot Target Volume Auto-Delineation

arXiv:2603.09448v2 Announce Type: replace-cross Abstract: Delineating the clinical target volume (CTV) in radiotherapy involves complex margins constrained by tumor location and anatomical barriers. While deep learning models automate this process, their rigid reliance on expert-annotated data requires costly retraining whenever clinical guidelines update. To overcome this limitation, we introduce OncoAgent, a novel guideline-aware AI agent framework that seamlessly converts textual clinical guidelines into three-dimensional target contours in a training-free manner. Evaluated on esophageal ca

Why this matters
Why now

The increasing sophistication of large language models and multi-modal AI makes it possible to translate complex, unstructured textual guidelines into actionable, precise outputs for domains like medical imaging.

Why it’s important

This development allows for a significant acceleration and cost reduction in the deployment of AI in critical medical applications, bypassing the traditional bottlenecks of expert data annotation and retraining with every guideline update.

What changes

AI models can now adapt to evolving clinical standards without extensive and expensive manual re-annotation, enabling broader and faster integration into healthcare workflows.

Winners
  • · Healthcare providers
  • · AI-driven diagnostic companies
  • · Patients
  • · Radiotherapy equipment manufacturers
Losers
  • · Manual annotation services
  • · Legacy medical imaging software
Second-order effects
Direct

Radiotherapy planning becomes more efficient and consistent, reducing human error and improving patient outcomes.

Second

The cost of developing and maintaining AI in medical imaging decreases dramatically, encouraging wider adoption across various specialties.

Third

This paradigm shift could lead to a democratization of advanced medical AI, making high-quality diagnostics and treatment planning accessible in resource-limited settings worldwide.

Editorial confidence: 90 / 100 · Structural impact: 60 / 100
Original report

This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.

Read at arXiv cs.AI
Tracked by The Continuum Brief · live intelligence network
Share
The Brief · Weekly Dispatch

Stay ahead of the systems reshaping markets.

By subscribing, you agree to receive updates from THE CONTINUUM BRIEF. You can unsubscribe at any time.